| HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study RK Heaton, DB Clifford, DR Franklin Jr, SP Woods, C Ake, F Vaida, ... Neurology 75 (23), 2087-2096, 2010 | 2710 | 2010 |
| HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors RK Heaton, DR Franklin, RJ Ellis, JA McCutchan, SL Letendre, S LeBlanc, ... Journal of neurovirology 17, 3-16, 2011 | 1811 | 2011 |
| Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system S Letendre, J Marquie-Beck, E Capparelli, B Best, D Clifford, AC Collier, ... Archives of neurology 65 (1), 65-70, 2008 | 1019 | 2008 |
| CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy RJ Ellis, J Badiee, F Vaida, S Letendre, RK Heaton, D Clifford, AC Collier, ... Aids 25 (14), 1747-1751, 2011 | 520 | 2011 |
| Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance CM Marra, Y Zhao, DB Clifford, S Letendre, S Evans, K Henry, RJ Ellis, ... Aids 23 (11), 1359-1366, 2009 | 443 | 2009 |
| Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study RK Heaton, DR Franklin Jr, R Deutsch, S Letendre, RJ Ellis, K Casaletto, ... Clinical Infectious Diseases 60 (3), 473-480, 2015 | 434 | 2015 |
| Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy TH Burdo, MR Lentz, P Autissier, A Krishnan, E Halpern, S Letendre, ... Journal of Infectious Diseases 204 (1), 154-163, 2011 | 405 | 2011 |
| Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline I Grant, DR Franklin Jr, R Deutsch, SP Woods, F Vaida, RJ Ellis, ... Neurology 82 (23), 2055-2062, 2014 | 388 | 2014 |
| Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life AT Rodriguez-Penney, JE Iudicello, PK Riggs, K Doyle, RJ Ellis, ... AIDS patient care and STDs 27 (1), 5-16, 2013 | 375 | 2013 |
| Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy LA Cysique, F Vaida, S Letendre, S Gibson, M Cherner, SP Woods, ... Neurology 73 (5), 342-348, 2009 | 357 | 2009 |
| Circuit party attendance, club drug use, and unsafe sex in gay men AM Mattison, MW Ross, T Wolfson, D Franklin, ... Journal of substance abuse 13 (1-2), 119-126, 2001 | 349 | 2001 |
| Controversies in HIV-associated neurocognitive disorders S Nightingale, A Winston, S Letendre, BD Michael, JC McArthur, S Khoo, ... The Lancet Neurology 13 (11), 1139-1151, 2014 | 341 | 2014 |
| Neurologic complications of HIV disease and their treatment SL Letendre, RJ Ellis, BM Ances, JA McCutchan Topics in HIV medicine: a publication of the International AIDS Society, USA …, 2010 | 327 | 2010 |
| Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder S Letendre Topics in antiviral medicine 19 (4), 137, 2011 | 308 | 2011 |
| Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders SL Letendre, JA McCutchan, ME Childers, SP Woods, D Lazzaretto, ... Annals of neurology 56 (3), 416-423, 2004 | 307 | 2004 |
| Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection TH Burdo, A Weiffenbach, SP Woods, S Letendre, RJ Ellis, KC Williams Aids 27 (9), 1387-1395, 2013 | 293 | 2013 |
| Pathogenesis of HIV in the central nervous system V Valcour, P Sithinamsuwan, S Letendre, B Ances Current Hiv/aids Reports 8, 54-61, 2011 | 290 | 2011 |
| Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort M Smurzynski, K Wu, S Letendre, K Robertson, RJ Bosch, DB Clifford, ... Aids 25 (3), 357-365, 2011 | 269 | 2011 |
| Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy RJ Ellis, ME Childers, M Cherner, D Lazzaretto, S Letendre, ... The Journal of infectious diseases 188 (12), 1820-1826, 2003 | 250 | 2003 |
| Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy I Everall, F Vaida, N Khanlou, D Lazzaretto, C Achim, S Letendre, ... Journal of neurovirology 15, 360-370, 2009 | 247 | 2009 |
